04.10.24 -- From Ally To Adversary: BIO's Swift Rebuke Of WuXi

Join us on May 1st to learn the latest in nanotechnology. Recent developments in leading nanotechnologies are enabling new formulation possibilities for more products, providing a better patient experience and stronger differentiation for biopharma innovators. Discover new data on nanotechnology and how to tackle drug loading and pill burden issues associated with amorphous solid dispersion formulations. Click here to learn more.

The ISPE's Drug Shortages Prevention Model revamps its predecessor, the more prescriptive Drug Shortages Prevention Plan, with a focus on 12 key performance areas.

The formulation and spray drying process can help manufacture a stable, highly respirable powder and deliver products that require a high drug load, a biologic, or rapid onset therapeutic.

Because scale-up and technology transfer of the lyophilization process is challenging, it is important to develop a comprehensive understanding of critical lyophilization characteristics early on.

The FDA nitrosamine contamination guidance set deadlines of Nov. 1, 2023, for risk assessment updates and Aug. 1, 2025, for full NDSRI limit compliance.

Leveraging computer-aided synthesis design technology and route scouting early can aid you in designing an efficient and cost-effective path to API manufacturing.

Review a commercially-ready process not only capable of reproducing spray dried dispersions with less manufacturing complexity and environmental impact, but also with the capability to out-design and outperform spray drying.

Discover Nanoform’s manufacturing capabilities, its CESS technology for nanoparticle generation, and the types of particles that can be generated without the need for solvents or excipients.

Finding a partner with integrated services is crucial for accelerating timelines and accessing solutions with comprehensive expertise, all while removing risk from the drug product lifecycle.